Cyclophosphamide versus methylprednisolone for treating neuropsychiatric involvement in systemic lupus erythematosus.
暂无分享,去创建一个
[1] H. Yamanaka,et al. Anti-NR2A antibody as a predictor for neuropsychiatric systemic lupus erythematosus. , 2011, Rheumatology.
[2] W. Mccune,et al. Treatment of non-renal lupus , 2011 .
[3] J. Ioannidis,et al. EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs , 2010, Annals of the rheumatic diseases.
[4] P. Clark,et al. Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus , 2005, Annals of the rheumatic diseases.
[5] C. Lavalle,et al. Trends of anticardiolipin antibodies after low-dose methylprednisolone and cyclophosphamide treatment of systemic lupus erythematosus. , 2004, Archives of medical research.
[6] C. Gordon,et al. EULAR randomised controlled trial of pulse cyclophosphamide and methylprednisolone versus continuous cyclophosphamide and prednisolone followed by azathioprine and prednisolone in lupus nephritis , 2004, Annals of the rheumatic diseases.
[7] T. Lehman,et al. Combined intravenous methotrexate and cyclophosphamide for refractory childhood lupus nephritis , 2004, Annals of the rheumatic diseases.
[8] M. Kopelman,et al. A psychiatric perspective on the therapy of psychosis in systemic lupus erythematosus , 2003, Lupus.
[9] C. Lau,et al. Treatment of lupus psychosis with oral cyclophosphamide followed by azathioprine maintenance: an open-label study. , 2003, The American journal of medicine.
[10] M. Vilardell‐Tarrés,et al. Predictors of poor renal outcome in patients with lupus nephritis treated with combined pulses of cyclophosphamide and methylprednisolone , 2003, Lupus.
[11] L. Stojanovich,et al. Neuropsychiatric lupus favourable response to low dose i.v. cyclophosphamide and prednisolone (pilot study) , 2003, Lupus.
[12] A. Steinberg,et al. Methylprednisolone and Cyclophosphamide, Alone or in Combination, in Patients with Lupus Nephritis , 1996, Annals of Internal Medicine.
[13] G. Hughes,et al. Pulse cyclophosphamide in the treatment of neuropsychiatric systemic lupus erythematosus. , 1996, Clinical and experimental rheumatology.
[14] A R Jadad,et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? , 1996, Controlled clinical trials.
[15] B. Fessler,et al. Systemic Lupus Erythematosus: Emerging Concepts: Part 1: Renal, Neuropsychiatric, Cardiovascular, Pulmonary, and Hematologic Disease , 1995, Annals of Internal Medicine.
[16] J. Denburg,et al. Nervous system lupus: pathogenesis and rationale for therapy. , 1995, Scandinavian journal of rheumatology.
[17] D. Borenstein,et al. Role of intravenous cyclophosphamide in the treatment of severe neuropsychiatric systemic lupus erythematosus. , 1995, The American journal of medicine.
[18] K. Dickersin,et al. Systematic Reviews: Identifying relevant studies for systematic reviews , 1994 .
[19] J. Denburg,et al. Corticosteroids and neuropsychological functioning in patients with systemic lupus erythematosus. , 1994, Arthritis and rheumatism.
[20] G. Kirsztajn,et al. A Controlled Trial of Pulse Cydophosphamide Versus Pulse Methylprednisolone in Severe Lupus Nephritis , 1994, Lupus.
[21] A. Steinberg,et al. Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis , 1992, The Lancet.
[22] E. Lewis,et al. Progression and Remission of Renal Disease in the Lupus Nephritis Collaborative Study , 1992, Annals of Internal Medicine.
[23] J. Sibley,et al. The incidence and prognosis of central nervous system disease in systemic lupus erythematosus. , 1992, The Journal of rheumatology.
[24] A. Vercellone,et al. Intravenous cyclophosphamide pulse therapy in the treatment of systemic lupus erythematosus. Long-term results. , 1992, Contributions to nephrology.
[25] H. Euler,et al. A Randomized Trial of Plasmapheresis and Subsequent Pulse Cyclophosphamide in Severe Lupus: Design of the Lpsg Trial , 1991, The International journal of artificial organs.
[26] A. Steinberg,et al. Long-term preservation of renal function in patients with lupus nephritis receiving treatment that includes cyclophosphamide versus those treated with prednisone only. , 1991, Arthritis and rheumatism.
[27] O. Wolkowitz,et al. Cognitive effects of corticosteroids. , 1990, The American journal of psychiatry.
[28] A. Myers,et al. Lupus Nephritis: Efficacy of Monthly Pulse Therapy With Intravenous Methylprednisolone , 1989, Southern medical journal.
[29] G. Hughes,et al. A double blind, placebo controlled trial of intravenous methylprednisolone in systemic lupus erythematosus. , 1988, Annals of the rheumatic diseases.
[30] W. Mccune,et al. Neuropsychiatric lupus. , 1988, Rheumatic diseases clinics of North America.
[31] D. Isenberg,et al. A double blind controlled trial of methylprednisolone infusions in systemic lupus erythematosus using individualised outcome assessment. , 1987, Annals of the Rheumatic Diseases.
[32] N. Brot,et al. Association between lupus psychosis and anti-ribosomal P protein antibodies. , 1987, The New England journal of medicine.
[33] P H Plotz,et al. Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs. , 1986, The New England journal of medicine.
[34] J. Klinenberg,et al. The neuropsychiatric manifestations of systemic lupus erythematosus: an overview. , 1986, Seminars in arthritis and rheumatism.
[35] D. Felson,et al. Evidence for the superiority of immunosuppressive drugs and prednisone over prednisone alone in lupus nephritis. Results of a pooled analysis. , 1984, The New England journal of medicine.
[36] O. Henriksen,et al. The reflex sympathetic dystrophy syndrome. An experimental study of sympathetic reflex control of subcutaneous blood flow in the hand. , 1983, Scandinavian journal of rheumatology.
[37] J F Fries,et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.
[38] J. Kasdin,et al. Monthly pulses of methylprednisolone in SLE nephritis. , 1982, The Journal of rheumatology.
[39] A. Steinberg,et al. Alternative modes of cyclophosphamide and azathioprine therapy in lupus nephritis. , 1982, Annals of internal medicine.
[40] S. Ballou,et al. Clinical features of systemic lupus erythematosus: differences related to race and age of onset. , 1982, Arthritis and rheumatism.
[41] M. Benson,et al. Methylprednisolone pulse therapy for nonrenal lupus erythematosus. , 1980, Annals of the rheumatic diseases.
[42] K. E. Holley,et al. Treatment of diffuse proliferative lupus nephritis with prednisone and combined prednisone and cyclophosphamide. , 1978, The New England journal of medicine.
[43] H. Mcdevitt,et al. Cyclophosphamide therapy in systemic lupus erythematosus and polymyositis. , 1973, Arthritis and rheumatism.
[44] A. Steinberg,et al. Cyclophosphamide in lupus nephritis: a controlled trial. , 1971, Annals of internal medicine.